About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
Prof. Eran Segal provides an update on his symptom-tracking questionnaire and how it can help predict the second wave of COVID-19. As he explains, testing is insufficient...
June 10, 2020
In this special update from his home in New York City, CEO Dave Doneson discusses the Weizmann Institute’s remarkable coronavirus response. Dave shares how the Institute has rapidly shifted its focus to address the pandemic, transforming into one of the world’s leading hubs of COVID-19 research. Weizmann scientists are fighting this disease on a variety of fronts, offering hope and optimism for us all.
June 02, 2020
In this video from a session at the United Nations’ 2020 Science, Technology, and Innovation (STI) conference, Prof. Ada Yonath speaks about COVID: its makeup, how it compares with other viruses, possible avenues of treatment, and challenges.
May 21, 2020
Dr. Nir London discusses the “COVID Moonshot” project in this videoconference. The global initiative, which currently includes nine partners, aims to develop a “cheap and safe” antiviral treatment for COVID on a much faster timeline than traditional drug discovery.
May 17, 2020
In this video, Profs. Ron Milo and Uri Alon succinctly and clearly explain their “intermittent work” strategy for restarting the economy without triggering a new wave of COVID infections.
May 04, 2020
Dr. Ori Avinoam of Weizmann’s Department of Biomolecular Sciences presents an overview of his lab’s coronavirus research. His team has created a pseudovirus, which has all the elements of the coronavirus but is not infectious.
April 28, 2020
Public health expert Prof. Gabi Barbash outlines the pandemic’s many unknowns: How many people are asymptomatic and yet spreading the virus? Why do some patients have mild symptoms, while others become severely ill? Are recovered patients with coronavirus antibodies now immune?
April 27, 2020
In this videoconference hosted by Weizmann Canada, Profs. Uri Alon and Ron Milo present their bioinformatics-based exit strategy, which Prof. Milo describes as “‘biology by the numbers’ meets the coronavirus.”
April 26, 2020
As he discusses in this video, Prof. Sarel Fleishman of the Department of Biomolecular Sciences is supporting multiple lines of coronavirus research at Weizmann – including his own.
April 22, 2020
©2020 American Committee for the Weizmann Institute of Science